GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » Total Current Assets

Oncimmune Holdings (LSE:ONC) Total Current Assets : £1.85 Mil (As of Aug. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Oncimmune Holdings's total current assets for the quarter that ended in Aug. 2024 was £1.85 Mil.


Oncimmune Holdings Total Current Assets Historical Data

The historical data trend for Oncimmune Holdings's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings Total Current Assets Chart

Oncimmune Holdings Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 Aug23 Aug24
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.23 11.14 9.97 5.57 1.85

Oncimmune Holdings Semi-Annual Data
Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Feb23 Aug23 Feb24 Aug24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.97 2.72 5.57 3.24 1.85

Oncimmune Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Oncimmune Holdings's Total Current Assets for the fiscal year that ended in Aug. 2024 is calculated as

Oncimmune Holdings's Total Current Assets for the quarter that ended in Aug. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Oncimmune Holdings  (LSE:ONC) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Oncimmune Holdings's Liquidation Value for the quarter that ended in Aug. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.846-7.301+0.75 * 0.311+0.5 * 0.238
=-6.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncimmune Holdings Total Current Assets Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncimmune Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacturing, and commercialization of personalized immunodiagnostics for the screening, detection, and care of cancer. The company's operating segment is ImmunoINSIGHTS.